ALC
Price
$80.03
Change
+$0.83 (+1.05%)
Updated
Dec 3 closing price
Capitalization
39.08B
89 days until earnings call
Intraday BUY SELL Signals
RMD
Price
$251.34
Change
+$0.49 (+0.20%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
36.26B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALC vs RMD

Header iconALC vs RMD Comparison
Open Charts ALC vs RMDBanner chart's image
Alcon
Price$80.03
Change+$0.83 (+1.05%)
Volume$1.4M
Capitalization39.08B
ResMed
Price$251.34
Change+$0.49 (+0.20%)
Volume$7.94K
Capitalization36.26B
ALC vs RMD Comparison Chart in %
ALC
Daily Signal:
Gain/Loss:
RMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALC vs. RMD commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a StrongBuy and RMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ALC: $79.21 vs. RMD: $250.90)
Brand notoriety: ALC and RMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALC: 25% vs. RMD: 24%
Market capitalization -- ALC: $38.97B vs. RMD: $36.26B
ALC [@Pharmaceuticals: Other] is valued at $38.97B. RMD’s [@Pharmaceuticals: Other] market capitalization is $36.26B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $201.13B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileRMD’s FA Score has 0 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • RMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RMD is a better buy in the long-term than ALC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 5 TA indicator(s) are bullish while RMD’s TA Score has 5 bullish TA indicator(s).

  • ALC’s TA Score: 5 bullish, 4 bearish.
  • RMD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RMD is a better buy in the short-term than ALC.

Price Growth

ALC (@Pharmaceuticals: Other) experienced а -0.56% price change this week, while RMD (@Pharmaceuticals: Other) price change was -1.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.16%. For the same industry, the average monthly price growth was +6.95%, and the average quarterly price growth was +2.84%.

Reported Earning Dates

ALC is expected to report earnings on Mar 03, 2026.

RMD is expected to report earnings on Jan 22, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-0.16% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALC($39.1B) has a higher market cap than RMD($36.3B). ALC has higher P/E ratio than RMD: ALC (38.11) vs RMD (25.42). RMD YTD gains are higher at: 10.427 vs. ALC (-6.691). ALC has higher annual earnings (EBITDA): 2.74B vs. RMD (1.92B). ALC has more cash in the bank: 1.41B vs. RMD (1.21B). RMD has less debt than ALC: RMD (852M) vs ALC (5.25B). ALC has higher revenues than RMD: ALC (10B) vs RMD (5.15B).
ALCRMDALC / RMD
Capitalization39.1B36.3B108%
EBITDA2.74B1.92B143%
Gain YTD-6.69110.427-64%
P/E Ratio38.1125.42150%
Revenue10B5.15B194%
Total Cash1.41B1.21B116%
Total Debt5.25B852M616%
FUNDAMENTALS RATINGS
ALC vs RMD: Fundamental Ratings
ALC
RMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
5769
SMR RATING
1..100
8436
PRICE GROWTH RATING
1..100
5656
P/E GROWTH RATING
1..100
4368
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (37) in the Medical Specialties industry is somewhat better than the same rating for ALC (75) in the Hospital Or Nursing Management industry. This means that RMD’s stock grew somewhat faster than ALC’s over the last 12 months.

ALC's Profit vs Risk Rating (57) in the Hospital Or Nursing Management industry is in the same range as RMD (69) in the Medical Specialties industry. This means that ALC’s stock grew similarly to RMD’s over the last 12 months.

RMD's SMR Rating (36) in the Medical Specialties industry is somewhat better than the same rating for ALC (84) in the Hospital Or Nursing Management industry. This means that RMD’s stock grew somewhat faster than ALC’s over the last 12 months.

RMD's Price Growth Rating (56) in the Medical Specialties industry is in the same range as ALC (56) in the Hospital Or Nursing Management industry. This means that RMD’s stock grew similarly to ALC’s over the last 12 months.

ALC's P/E Growth Rating (43) in the Hospital Or Nursing Management industry is in the same range as RMD (68) in the Medical Specialties industry. This means that ALC’s stock grew similarly to RMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCRMD
RSI
ODDS (%)
Bearish Trend 6 days ago
50%
Bullish Trend 6 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
55%
Bearish Trend 6 days ago
58%
Momentum
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 6 days ago
67%
MACD
ODDS (%)
N/A
Bullish Trend 6 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
60%
Bullish Trend 6 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
57%
Bearish Trend 6 days ago
54%
Advances
ODDS (%)
Bullish Trend 22 days ago
58%
Bullish Trend 16 days ago
61%
Declines
ODDS (%)
Bearish Trend 14 days ago
58%
Bearish Trend 14 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
60%
Bullish Trend 6 days ago
67%
Aroon
ODDS (%)
Bullish Trend 6 days ago
49%
Bearish Trend 6 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signal:
Gain/Loss:
RMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BAMG40.040.22
+0.55%
Brookstone Growth Stock ETF
OMFL60.640.18
+0.30%
Invesco Russell 1000® Dynamic Mltfct ETF
MVRL14.94N/A
N/A
ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN
QQLV24.37N/A
-0.01%
Invesco QQQ Low Volatility ETF
CHW7.27-0.05
-0.68%
Calamos Global Dynamic Income Fund

ALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALC
1D Price
Change %
ALC100%
+1.29%
SYK - ALC
54%
Loosely correlated
-1.51%
A - ALC
54%
Loosely correlated
-0.85%
DHR - ALC
53%
Loosely correlated
+1.11%
TMO - ALC
53%
Loosely correlated
-0.84%
COO - ALC
53%
Loosely correlated
-2.05%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+1.01%
SOLV - RMD
51%
Loosely correlated
+0.01%
NVST - RMD
47%
Loosely correlated
-2.86%
BLCO - RMD
44%
Loosely correlated
+3.02%
ALC - RMD
40%
Loosely correlated
+1.29%
RVTY - RMD
40%
Loosely correlated
+0.33%
More